FDA Releases Draft Guidance on Evaluating Safety of Drug Combinations

Summary

The Food and Drug Administration (FDA) has made available a draft guidance document outlining nonclinical safety evaluation approaches for fixed-dose combination products, copackaged products, and adjunctive therapies, aiming to support their clinical study and approval.